Manufacturing

Articles

Curia and the US government have entered into a cooperative agreement to expand fill/finish capability for injectable medicines.

Curia Enters Cooperative Agreement with US Government to Expand Sterile Fill/Finish Capability

Jennifer Markarian is manufacturing editor of BioPharm International.

The continuous, aseptic fill/finish process is finding use in vaccines and biologic drugs. 

Considering Blow-Fill-Seal for Biologic Drugs

Moderna and Thermo Fisher Scientific have formed a collaboration to leverage dedicated commercial fill/finish manufacturing capacity in the US for mRNA vaccines and therapies.

Moderna and Thermo Fisher Scientific Form Long-Term Strategic Manufacturing Collaboration

Fareva plans to use blow-fill-seal equipment and ApiJect’s prefilled injector technology to create fill/finish capacity in France.

Fareva and ApiJect Plan Vaccine Packaging Capacity in France 

Disposable equipment components find use in small-volume aseptic biopharmaceutical manufacturing.

Single-Use Systems Enhance Flexibility 

Global CDMO, ten23 health, has acquired filling technology and drug product manufacturing expert, swissfillon, enhancing its integrated offering.

ten23 health Acquires swissfillon to Enhance its Integrated Offering

Cynthia A. Challener, PhD, is a contributing editor to BioPharm International.

Alternative materials, as well as supply-chain planning, are essential to ensure a reliable supply for parenteral drug packaging.

Setting a Clear Strategy for Primary Packaging

Lonza plans to establish drug product manufacturing capabilities at is site in Guangzhou, China, to produce clinical trial and commercial supply in the country.

Lonza Invests in Drug Product Manufacturing Services in China

Jorge Ferreira is fill/finish subject matter expert at Jacobs, 

Lora Zeanchock is project manager at Jacobs.

Scenario modeling informs planning for current and future manufacturing needs. 

Designing Flexible Fill/Finish Facilities

Amgen’s greenfield facility near Columbus, Ohio to assemble and package vials and syringes is expected to be operational by 2024. 

Manufacturing, Fill/Finish